Dimed S.A. Distribuidora de Medicamentos (PNVL3) — Capital Reinvestment Ratio
Dimed S.A. Distribuidora de Medicamentos (PNVL3) has a Capital Reinvestment Ratio of 0.20x as of December 2025, meaning it reinvests 0% of its operating cash flow (R$125.39 Million) in capital expenditures (R$25.37 Million). See PNVL3 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dimed S.A. Distribuidora de Medicamentos Capital Reinvestment Ratio (2000–2025)
This chart tracks Dimed S.A. Distribuidora de Medicamentos's Capital Reinvestment Ratio across 26 annual periods. Check Dimed S.A. Distribuidora de Medicamentos (PNVL3) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Dimed S.A. Distribuidora de Medicamentos (2000–2025)
Year-by-year Capital Reinvestment Ratio for Dimed S.A. Distribuidora de Medicamentos from 2000 to 2025. For live market cap and broader valuation context, see PNVL3 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (BRL) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.29x | R$421.29 Million | R$122.15 Million | ▼ -58.8% |
| 2024 | 0.70x | R$224.45 Million | R$157.83 Million | ▲ +49.6% |
| 2023 | 0.47x | R$296.62 Million | R$139.44 Million | ▼ -46.8% |
| 2022 | 0.88x | R$205.48 Million | R$181.64 Million | ▼ -14.0% |
| 2021 | 1.03x | R$131.86 Million | R$135.58 Million | ▲ +58.8% |
| 2020 | 0.65x | R$130.98 Million | R$84.80 Million | ▲ +54.8% |
| 2019 | 0.42x | R$128.80 Million | R$53.87 Million | ▼ -22.0% |
| 2018 | 0.54x | R$109.88 Million | R$58.95 Million | ▼ -49.3% |
| 2017 | 1.06x | R$40.88 Million | R$43.25 Million | ▲ +185.6% |
| 2016 | 0.37x | R$101.60 Million | R$37.63 Million | ▼ -15.9% |
| 2015 | 0.44x | R$72.56 Million | R$31.97 Million | ▼ -99.7% |
| 2014 | 171.98x | R$324.00K | R$55.72 Million | ▲ +11908.8% |
| 2013 | 1.43x | R$62.30 Million | R$89.22 Million | ▲ +2.3% |
| 2012 | 1.40x | R$19.24 Million | R$26.94 Million | ▲ +170.6% |
| 2011 | 0.52x | R$50.59 Million | R$26.18 Million | ▼ -76.9% |
| 2010 | 2.24x | R$8.08 Million | R$18.06 Million | ▲ +507.4% |
| 2009 | 0.37x | R$39.61 Million | R$14.58 Million | ▼ -70.7% |
| 2008 | 1.26x | R$10.21 Million | R$12.84 Million | ▲ +278.6% |
| 2007 | 0.33x | R$16.38 Million | R$5.44 Million | ▲ +17.0% |
| 2006 | 0.28x | R$13.10 Million | R$3.72 Million | ▼ -50.5% |
| 2005 | 0.57x | R$7.86 Million | R$4.51 Million | ▲ +139.0% |
| 2004 | 0.24x | R$15.58 Million | R$3.74 Million | ▼ -16.8% |
| 2003 | 0.29x | R$14.54 Million | R$4.20 Million | ▼ -50.8% |
| 2002 | 0.59x | R$8.60 Million | R$5.04 Million | ▲ +44.2% |
| 2001 | 0.41x | R$12.45 Million | R$5.06 Million | ▼ -26.4% |
| 2000 | 0.55x | R$7.72 Million | R$4.26 Million | — |